Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tetanus/Diphtheria Vaccine In Shortage; CDC Prioritizes Travel Immunizations

Executive Summary

Adult tetanus/diphtheria vaccine is in short supply following cessation of manufacturing by Wyeth-Ayerst and retooling of a plant by Aventis.

You may also be interested in...

Wyeth Will Lose 18.5% Of Marietta Sales If Firm Does Not Comply With GMPs

Wyeth-Ayerst would have to pay the government 18.5% of future net sales from products manufactured at its Marietta, Penn. facility if it fails to meet a timeline for bringing the plant into compliance with current Good Manufacturing Practices under an Oct. 3 consent decree with FDA.

FDA Concerned By Shrinking Vaccine Supplier Pool, CBER's Zoon Says

The potential for vaccine manufacturers to exit the business is "very troubling" to FDA, Center for Biologics Evaluation & Research Director Kathryn Zoon, PhD, told the Regulatory Affairs Professionals Society annual meeting in Washington, D.C. Oct. 4.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts